News & Updates
Filter by Specialty:
Do multivitamins increase prostate cancer risk in older men?
Taking multivitamins regularly or for a long duration neither heightens nor reduces the risk of overall or aggressive prostate cancer among older, generally well-nourished men, results of a study have shown.
Do multivitamins increase prostate cancer risk in older men?
31 Aug 2022
Relugolix leads to rapid, sustained profound testosterone suppression in advanced PCa
Use of the oral non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix led to faster and greater sustained profound testosterone suppression than leuprolide in men with advanced prostate cancer, according to results of the phase III HERO study presented at EAU 2022.
Relugolix leads to rapid, sustained profound testosterone suppression in advanced PCa
25 Aug 2022
Is 5-year interval sufficient for prostate cancer screening in older men?
Diagnosis, progression, or death due to prostate cancer occur at approximately a decade to 15 years following an initial assessment of prostate-specific antigen (PSA) levels in older men, according to a study presented at EAU 2022.
Is 5-year interval sufficient for prostate cancer screening in older men?
18 Aug 2022
Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
In men with intermediate- or high-risk prostate cancer (PCa), local failure after definitive radiation therapy (RT) is indicative of survival outcomes, according to a recent study.
